Targeting Bruton Tyrosine Kinase: A novel strategy in the treatment of B-cell lymphomas Cover

.blurhash-client-img { display: none !important; }

Targeting Bruton Tyrosine Kinase: A novel strategy in the treatment of B-cell lymphomas

Forum of Clinical Oncology

Volume 8 (2017): Issue 1 (June 2017)

By: R. Sklavenitis-Pistofidis, T. Koletsa, A. Lazaridou and A. Goulas

Open Access

|Jun 2017

Authors

R. Sklavenitis-Pistofidis

1st Laboratory of Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

T. Koletsa

Department of Pathology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

A. Lazaridou

1st Laboratory of Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

A. Goulas

goulas@med.auth.gr

1st Laboratory of Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

DOI: https://doi.org/10.1515/fco-2015-0026 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 7 - 14

Submitted on: Sep 8, 2016

|

Accepted on: Aug 24, 2017

|

Published on: Jun 30, 2017

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2017 R. Sklavenitis-Pistofidis, T. Koletsa, A. Lazaridou, A. Goulas, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 8 (2017): Issue 1 (June 2017)Next article